At the Biomedical Advanced Research and Development Authority, BARDA, We are innovating not only in Science but in the way we do Business! We have a strong tradition of forming novel public private partnerships with industry that has positioned BARDA to support the approval of 43 FDA products in as few as 12 years. But like any industry partner with a track record of success, we also understand that our future success is largely dependent on a robust pipeline of R&D candidates.
In 2016, BARDA recommitted to Innovation and revitalizing our R&D pipeline, through the formation of novel external partnerships. Join us for our panel as we discuss how BARDA is leveraging new partnership models that are fundamentally changing the way Government is investing in and promoting disruptive innovation. These new models are enabling BARDA to bring together the best ideas from the medical, scientific and Biotech communities, together with government and venture capital investment, to drive innovation that will strengthen our nation’s capabilities to respond to 21st Century Health Security Threats.
Our panel will include representatives from our new innovative partnership models (CARB-X, DRIVe, JLABs@WashingtonDC). Learn how they are providing wrap around financial, business and infrastructure resources to support innovators and product developers across all stages of medical countermeasure development. Hear the benefits of being “Powered by BARDA” and how a strategic partnership with BARDA may help you unlock follow-on dilutive and non-dilutive capital! Meet our network of Accelerators from across the country and learn how they are helping BARDA decentralize innovation and identify, invest in and accelerate promising products from the bench to the bedside.
At BARDA we are committed to fostering partnerships that can keep up with the speed of your innovation.
Session ID: 560415